
Sign up to save your podcasts
Or
Colorectal cancers are rising among people under age 50. There are a number of theories as to why and also promising data around early detection. In today’s episode: A deep dive into the epidemiology of colorectal cancers including who is most at risk, a look at the screening tools currently available, and why blood tests may be even more valuable than costly and invasive colonoscopies.
Guest:Dr. Otis Brawley is a globally-recognized expert in cancer prevention and control whose work focuses on developing cancer screening strategies and ensuring their effectiveness. He is a Bloomberg Distinguished Professor and faculty at the Johns Hopkins Bloomberg School of Public Health in epidemiology with a joint appointment in oncology at Johns Hopkins Medicine. He was the former Chief Medical Officer of the American Cancer Society.
Host:Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs, the largest center at the Johns Hopkins Bloomberg School of Public Health.
Show links and related content:Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death—The New England Journal of Medicine
A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening—The New England Journal of Medicine
The Minnesota Colon Cancer Control Study
Have a question about something you heard? Want to suggest a topic or guest? Contact us via email or visit our website.
Follow us:@PublicHealthPod on X
@JohnsHopkinsSPH on Instagram
@JohnsHopkinsSPH on Facebook
@PublicHealthOnCall on YouTube
Here's our RSS feed
4.6
613613 ratings
Colorectal cancers are rising among people under age 50. There are a number of theories as to why and also promising data around early detection. In today’s episode: A deep dive into the epidemiology of colorectal cancers including who is most at risk, a look at the screening tools currently available, and why blood tests may be even more valuable than costly and invasive colonoscopies.
Guest:Dr. Otis Brawley is a globally-recognized expert in cancer prevention and control whose work focuses on developing cancer screening strategies and ensuring their effectiveness. He is a Bloomberg Distinguished Professor and faculty at the Johns Hopkins Bloomberg School of Public Health in epidemiology with a joint appointment in oncology at Johns Hopkins Medicine. He was the former Chief Medical Officer of the American Cancer Society.
Host:Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs, the largest center at the Johns Hopkins Bloomberg School of Public Health.
Show links and related content:Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death—The New England Journal of Medicine
A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening—The New England Journal of Medicine
The Minnesota Colon Cancer Control Study
Have a question about something you heard? Want to suggest a topic or guest? Contact us via email or visit our website.
Follow us:@PublicHealthPod on X
@JohnsHopkinsSPH on Instagram
@JohnsHopkinsSPH on Facebook
@PublicHealthOnCall on YouTube
Here's our RSS feed
139 Listeners
5 Listeners
2,058 Listeners
40 Listeners
24 Listeners
507 Listeners
43,883 Listeners
4 Listeners
282 Listeners
111,156 Listeners
55,997 Listeners
478 Listeners
9 Listeners
46 Listeners
1,088 Listeners
16 Listeners
3 Listeners
4,488 Listeners
393 Listeners
6,255 Listeners
24 Listeners
227 Listeners
15,539 Listeners
82 Listeners